Please assess the completion status of the following clinical trial:

Trial Title: Study Evaluating Emergency-use Tigecycline in Subjects With Resistant Pathogens.

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Male or female subjects, greater than 8 years of age and a weight of more than 35 kilograms.~* Patients with current bacterial infections who have not responded to other available appropriate antibiotic therapies.~* Patient must give informed consent.~Exclusion Criteria:~* Patients with an expected survival of less than 2 weeks.~* Patients who have been designated as Do Not Resuscitate.~* Known or suspected hypersensitivity to tigecycline, tetracyclines, or other compounds related to this class of antibacterial agents.~* Pregnant women or nursing mothers.

- Gender: ALL
- Minimum Age: 8 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).